• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    MetLife Confirms First Quarter 2025 Series A Preferred Stock Dividend

    3/5/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email

    MetLife, Inc. (NYSE:MET) today announced that it has confirmed its previously announced declaration of the first quarter 2025 dividend of $0.35516415 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET).

    The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will set an ex-dividend date for the Series A preferred stock. The dividend will be payable March 17, 2025, to shareholders of record as of Feb. 28, 2025, due to the record date occurring on Sunday, March 2, 2025.

    About MetLife

    MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

    Forward-Looking Statements

    The forward-looking statements in this news release, using words such as "will," are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife's future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250305507366/en/

    For Media:

    Dave Franecki

    973-264-7465

    [email protected]

    For Investors:

    John Hall

    212-578-7888

    [email protected]

    Get the next $MET alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings